Front. Immunol. Frontiers in Immunology Front. Immunol. 1664-3224 Frontiers Media S.A. 10.3389/fimmu.2024.1382832 Immunology Correction Corrigendum: Identification of ACKR4 as an immune checkpoint in pulmonary arterial hypertension Jiang Chen-Yu 1 2 † Wu Li-Wei 1 2 † Liu Yi-Wei 1 2 Feng Bei 1 2 Ye Lin-Cai 1 2 Huang Xu 1 2 He Yang-Yang 3 Shen Yi 1 2 Zhu Yi-Fan 1 2 Zhou Xing-Liang 1 2 Jiang Dai-Ji 1 2 Qi Hai-Kun 4 * ‡ Zhang Hao 1 2 * ‡ Yan Yi 1 2 * ‡ 1 Shanghai Clinical Research Center for Rare Pediatric Diseases, Shanghai Children’s Medical Center (SCMC), School of Medicine, Shanghai Jiao Tong University, Shanghai, China 2 Heart Center and Shanghai Institute of Pediatric Congenital Heart Disease, Shanghai Children’s Medical Center (SCMC), School of Medicine, Shanghai Jiao Tong University, Shanghai, China 3 School of Pharmacy, Henan University, Kaifeng, Henan, China 4 School of Biomedical Engineering, Shanghaitech University, Shanghai, China

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

*Correspondence: Yi Yan, yannie0928@163.com; Hao Zhang, drzhanghao@126.com; Hai-Kun Qi, qihk@shanghaitech.edu.cn

†These authors have contributed equally to this work and share first authorship

‡These authors have contributed equally to this work and share last authorship

 20 02 2024 2024 15 1382832 06 02 2024 07 02 2024 Copyright © 2024 Jiang, Wu, Liu, Feng, Ye, Huang, He, Shen, Zhu, Zhou, Jiang, Qi, Zhang and Yan 2024 Jiang, Wu, Liu, Feng, Ye, Huang, He, Shen, Zhu, Zhou, Jiang, Qi, Zhang and Yan

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Corrigendum on Identification of ACKR4 as an immune checkpoint in pulmonary arterial hypertension By Jiang C-Y, Wu L-W, Liu Y-W, Feng B, Ye L-C, Huang X, He Y-Y, Shen Y, Zhu Y-F, Zhou X-L, Jiang D-J, Qi H-K, Zhang H and Yan Y (2023) Front. Immunol. 14:1153573. doi: 10.3389/fimmu.2023.1153573 pulmonary arterial hypertension atypical chemokine receptor 4 transcriptomics chemokines immune National Natural Science Foundation of China10.13039/501100001809 section-in-acceptance Inflammation

In the original article, there was a mistake in the Funding statement as published. The Projects of National Natural Science Foundation of China (82200065, 82000064) were wrong. The correct Funding statement appears below.

FUNDING

“This work was supported by the Project of National Natural Science Foundation of China (U20A2018), the Project of Shanghai Municipal Science and Technology Commission (20MC1920400), the National Key Research and Development Program of China (2022YFC2703102), Projects of National Natural Science Foundation of China (82200065, 82241007), Shanghai Pujiang Program (22PJ1410100), Young Talent Program of Shanghai Municipal Health Commission (2022YQ070) and Innovative research team of high-level local universities in Shanghai.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.